Trivium Point Advisory LLC Has $1.42 Million Holdings in CME Group Inc. $CME

Trivium Point Advisory LLC trimmed its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 57.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,270 shares of the financial services provider’s stock after selling 7,050 shares during the quarter. Trivium Point Advisory LLC’s holdings in CME Group were worth $1,424,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of CME. Empowered Funds LLC increased its holdings in shares of CME Group by 11.5% during the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after purchasing an additional 1,037 shares during the period. Daymark Wealth Partners LLC bought a new stake in shares of CME Group in the second quarter valued at about $237,000. Arkadios Wealth Advisors grew its position in CME Group by 43.1% during the second quarter. Arkadios Wealth Advisors now owns 3,159 shares of the financial services provider’s stock worth $871,000 after buying an additional 951 shares in the last quarter. Hantz Financial Services Inc. increased its stake in CME Group by 83.8% during the second quarter. Hantz Financial Services Inc. now owns 329 shares of the financial services provider’s stock valued at $91,000 after acquiring an additional 150 shares during the period. Finally, Premier Path Wealth Partners LLC raised its holdings in CME Group by 8.7% in the 2nd quarter. Premier Path Wealth Partners LLC now owns 1,616 shares of the financial services provider’s stock valued at $445,000 after acquiring an additional 129 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling

In other CME Group news, Director William R. Shepard purchased 251 shares of the firm’s stock in a transaction that occurred on Tuesday, December 30th. The shares were acquired at an average cost of $278.37 per share, for a total transaction of $69,870.87. Following the transaction, the director directly owned 258,710 shares in the company, valued at approximately $72,017,102.70. The trade was a 0.10% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, CEO Terrence A. Duffy sold 25,000 shares of the firm’s stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the sale, the chief executive officer directly owned 65,804 shares of the company’s stock, valued at $17,737,468.20. This represents a 27.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 30,248 shares of company stock valued at $8,355,450 in the last ninety days. 0.30% of the stock is owned by corporate insiders.

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

  • Positive Sentiment: CME reported record 2025 results: $6.5B in revenue, AD volume rose 6% to 28.1M contracts (commodities +12%, financials +5%), highlighting continued franchise growth and fee-related revenue strength. This earnings strength is the primary bullish catalyst. CME Group (CME) Achieves Record 2025 Results with $6.5B in Revenue
  • Positive Sentiment: CME expanded physical-market infrastructure by approving the first aluminium warehousing facility in Taiwan, supporting commodities product growth and global market access for metals. That strengthens long-term fees and product diversification. CME approves first aluminium warehousing in Taiwan
  • Neutral Sentiment: Intraday data and flow reports show mixed signals: QuiverQuant flagged heavy volume and both insider selling and sizable institutional position changes (some managers added, some trimmed). This suggests active rebalancing rather than a clear directional bet. $CME stock is up 2% today. Here’s what we see in our data.
  • Neutral Sentiment: Reported short-interest data in the feed appears anomalous (zeros/NaN). No clear short-pressure signal is evident from that entry, so it shouldn’t be driving meaningful price moves. (Treat as data glitch/unreliable.)
  • Negative Sentiment: CME experienced a brief technical glitch that halted metals and natural gas trading on Globex and briefly pressured the stock when markets reacted; trading was subsequently restarted. Operational reliability concerns can weigh on near-term sentiment until fully resolved. CME Group halts metals and natural gas trading on technical issues
  • Negative Sentiment: Commentary criticizing CME’s Variable Storage Rate program (commodity storage economics) may pressure sentiment among some commodities market participants; impact is likely niche but could attract headlines. Why I Hate Variable Storage Rates

CME Group Stock Up 1.0%

Shares of NASDAQ CME opened at $319.50 on Friday. CME Group Inc. has a 52-week low of $248.53 and a 52-week high of $322.57. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.03. The business has a fifty day moving average of $287.63 and a two-hundred day moving average of $275.97. The stock has a market cap of $115.21 billion, a PE ratio of 28.63, a PEG ratio of 3.74 and a beta of 0.27.

CME Group (NASDAQ:CMEGet Free Report) last announced its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter last year, the company posted $2.52 EPS. The firm’s revenue for the quarter was up 8.1% on a year-over-year basis. As a group, equities research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th will be issued a dividend of $1.30 per share. The ex-dividend date of this dividend is Tuesday, March 10th. This is a positive change from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 annualized dividend and a dividend yield of 1.6%. CME Group’s dividend payout ratio (DPR) is 44.80%.

Wall Street Analyst Weigh In

CME has been the topic of several recent research reports. Barclays lifted their price objective on CME Group from $304.00 to $312.00 and gave the stock an “equal weight” rating in a report on Thursday, February 5th. Royal Bank Of Canada lifted their price target on shares of CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a research note on Thursday, February 5th. Jefferies Financial Group lowered their price target on shares of CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a report on Monday, January 12th. Piper Sandler raised their price objective on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on shares of CME Group from $312.00 to $316.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, CME Group currently has an average rating of “Hold” and an average price target of $299.53.

Get Our Latest Research Report on CME

CME Group Company Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.